Evidence
Pancreas. 2022 Nov-Dec 01;51(10):1320-1326. doi: 10.1097/MPA.0000000000002181.
ABSTRACT
OBJECTIVES: The histopathological changes in the liver and their clinical implication in chronic pancreatitis (CP) have not been studied well. We analyzed the incidence, risk factors, and long-term outcomes of these changes in CP.
METHODS: Chronic pancreatitis patients who underwent surgery with intraoperative liver biopsy from 2012 to 2018 formed the study group. Based on liver histopathology, 3 groups were formed: normal liver, group NL; fatty liver, group FL; and inflammation/fibrosis, group FS. The risk factors and long-term outcomes, including mortality, were evaluated.
RESULTS: Among 73 patients, 39 (53.4%) had idiopathic, and 34 (46.6%) had alcoholic CP. The median age was 32 years, 52 (71.2%) were males and comprised NL, n = 40 (55%); FL, n = 22 (30%); and FS, n = 11 (15%). The preoperative risk factors were comparable among NL and FL groups. Overall 14 of 73 patients (19.2%) (NL, 5 of 40; FL, 5 of 22; FS, 4 of 11 [P = 0.82]) had died at median follow-up of 36 months (range, 25-85 months). The main causes of mortality were tuberculosis and severe malnutrition secondary to pancreatic insufficiency.
CONCLUSIONS: The mortality is higher in patients with inflammation/fibrosis or steatosis in liver biopsy, and such patients need monitoring for progression of liver disease and pancreatic insufficiency.
PMID:37099773 | DOI:10.1097/MPA.0000000000002181
Add to Google Keep
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Histopathological Changes in Liver of Patients With Chronic Pancreatitis Requiring Surgical Intervention and Their Clinical Significance
🌐 90 Days
VR Related Evidence Matrix
- Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
- Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study
- COVID-19 in Individuals with Chronic Liver Diseases
- Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study
- Clinicopathological features of Sjogren's syndrome complicated with liver injury
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance, and anthropometric measurements in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial
- Significance of serum ferritin and De Ritis ratio in non-alcoholic fatty liver disease as diagnostic markers
- Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease
- Muscle Quality as a Potential Diagnostic Marker of Advanced Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
- Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- Role of prostaglandin E2 and its receptors in chronic liver disease
- Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
- Gallstones as a cause in presumed acute alcoholic pancreatitis: observational multicentre study
- Prognostic Value of Mitral Annular Calcification in Liver Transplant Patients: Implication in Posttransplant Outcomes
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- The Influence of Emodin Succinyl Ethyl Ester on Non-Alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice
- Liver fat as a dietary target by Chinese Medical Nutrition Therapy (CMNT) diet for treating type 2 diabetes with non-alcoholic fatty liver disease: study protocol for a randomised controlled trial
- The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism
- APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
- The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflurane Anesthesia for Pediatric Liver Surgery
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
- Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
- Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
- Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
- Fucoidan from Apostichopus japonicus ameliorates alcoholic liver disease by regulating gut-liver axis homeostasis
- Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets
- Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017-2018
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis
- Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
- Burden and correlates of significant liver fibrosis among HIV-infected and uninfected adults in urban Uganda
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
- New nomenclature for fatty liver disease
- Multivariate analysis and mathematical modeling of the informativeness of patients cases data in chronic pancreatitis associated with concomitant pathology
- Interleukins in liver disease treatment
- Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
- Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors
- Inflammatory liver diseases and susceptibility to sepsis
- Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology
- Does Autophagy have a Role in the Pathogenesis of Pediatric Hepatic Steatosis?
- Does Autophagy have a Role in the Pathogenesis of Pediatric Hepatic Steatosis?
- Serum miR‑29 is increased in mice with early liver fibrosis
- Evaluation of the non-alcoholic fatty liver fibrosis score in predicting short-term outcomes and severe coronary artery disease in patients undergoing coronary computed tomography angiography
- THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES
Evidence Blueprint
Histopathological Changes in Liver of Patients With Chronic Pancreatitis Requiring Surgical Intervention and Their Clinical Significance
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Histopathological Changes in Liver of Patients With Chronic Pancreatitis Requiring Surgical Intervention and Their Clinical Significance
🌐 365 Days
VR Related Evidence Matrix
- The Value of Liver Biopsy and Histology in Liver Disease Diagnosis and Patient Care-a Pragmatic Prospective Clinical Practice Study
- Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
- NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: a multi-center, retrospective study
- Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
- The First Successful Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report
- Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study
- Impact of fibrosis on liver-related event incidence in non-alcoholic fatty liver disease: A multicenter observational study
- The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Portal vein congestion index in patients with and without chronic liver disease
- Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease
- Co-existence of hepatic and pancreatic fibrosis in chronic pancreatitis patients including associated risk factors: a magnetic resonance elastography study
- COVID-19 in Individuals with Chronic Liver Diseases
- Influence of chronic liver diseases on the course and outcome of COVID-19
- Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
- Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort
- Factors that Influence the Acceptance of Needle Biopsy of the Liver at a Tertiary Hospital in Nigeria
- Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease
- Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study
- The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD
- Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study
- Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure
- Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
- Effects of curcumin on liver injury induced by chronic alcohol addiction
- Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
- Clinicopathological features of Sjogren's syndrome complicated with liver injury
- Application of noninvasive test (acoustic attenuation imaging and ultrasonic shear wave elastography) to grade nonalcoholic fatty liver disease: An observational study
- Liver fibrosis screening, evaluation pathway, and management in patients with fatty liver
- Endohepatology: The endoscopic armamentarium in the hand of the hepatologist
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Hormone action and liver disease, a complex interplay
- Unconjugated hyperbilirubinemia may exacerbate certain underlying chronic liver diseases
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
- The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance, and anthropometric measurements in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial
- Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
- Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
- Evaluation of neutrophil HDL-C ratio - a new inflammation marker in non-alcoholic fatty liver disease
- Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease
- Mononuclear myeloid-derived suppressor cells expansion is associated with progression of liver failure in patients with acute decompensation of cirrhosis
- Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease
- Liver health and the interplay between obesity, alcohol and bariatric surgery
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Metabolic Dysfunction-Associated Steatotic Liver Disease: A State-of-the-Art Review
- Role of NRF2 and reactive aldehydes in acute cellular rejection in liver transplant recipients
- Significance of serum ferritin and De Ritis ratio in non-alcoholic fatty liver disease as diagnostic markers
- Gallic acid improves liver cirrhosis by reducing oxidative stress and fibrogenesis in the liver of rats induced by bile duct ligation
- Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis
- Challenges and Opportunities in Developing Tailored Pain Management Strategies for Liver Patients
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An…
- Prevalence, distribution and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings
- Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study
- Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis